The U.S. Patent Trial and Appeal Board made a mistake in Medtronic's favor last year, a federal judge ruled this...
The funding for Elon Musk-backed Neuralink was in-part bolstered by FDA’s clearance to start N1 BCI human trials.
Sign up for the QMED & MD+DI Daily newsletter.